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Abstract 
Background: Periodontal disease has been reported to play a causative role in acute myocardial 
infarction (AMI), which may add to the various risk factors associated with coronary heart disease. The 
objective of the present study was to investigate the presence of Prevotella intermedia – an established 
periodontal pathogen – in subgingival plaque samples of chronic periodontitis and AMI patients in order 
to identify a possible association, and to evaluate the susceptibility of Prevotella intermedia to nine 
antimicrobial agents. Methods: After undergoing screening for eligibility, a total of 50 subjects were 
included in the present study. Twenty patients were diagnosed with AMI and generalized chronic 
periodontitis (Group I), 20 patients were diagnosed with only AMI (Group II), and 10 subjects were 
healthy controls (Group III). The isolated Prevotella intermedia strains were tested for susceptibility to 
bacitracin, chloramphenicol, penicillin G, polymyxin, gentamycin, neomycin, tetracycline, cefotaxime, and 
cefoxitin using an antibiotic zonescale to determine minimum inhibitory concentrations (MICs). Results: 
Periodontal pathogens were identified by phenotypic and enzymatic methods. The mean bacterial load 
of Prevotella intermedia species was higher in Group I compared to Group II and Group III. It was also 
found that pencillin G, gentamycin, neomycin, tetracycline, cefotaxime, and cefoxitin inhibited 90% of 
Prevotella intermedia, whereas bacitracin, chloramphenicol, and polymyxin inhibited 80% of Prevotella 
intermedia. Thus, only 10% of Prevotella intermedia were resistant to these antibiotics. Conclusion: The 
present study confirms that Prevotella intermedia is associated with chronic periodontitis and AMI. 
Keywords: Acute myocardial infarction; periodontal disease; Prevotella intermedia; antimicrobial 
susceptibility.
Introduction 
Coronary heart disease results from several 
environmental and genetic risk factors such as 
age, abnormal serum lipids, diabetes, smoking, 
hypertension, and viral and bacterial infections. 
These known risk factors, independently or 
combined, are involved in both myocardial 
infarction and atherosclerosis which are the 
leading cause of adult mortality and morbidity 
throughout the world.1,2,3 A relationship between 
periodontal disease and systemic diseases such 
as cardiovascular disease has been proposed, 
as they share common risk factors including age, 
abnormal serum lipids, diabetes, smoking, and 
viral and bacterial infections. Haffajee and 
Socransky suggested that several subgingival 
species, including Porphyromonas gingivalis, 
Prevotella intermedia, and Aggregatibacter 
actinomycetemcomitans, were associated with 
atheromatous lesions in the carotid arteries and 
found that over 40% of atheromas contain 
antigens for these periodontal pathogens. The 
endotoxins released from subgingival species 
may pass into systemic circulation and contribute 
to the formation of atheromas. The basis for the 
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biological mechanism of this relationship has 
been acknowledged and has driven an active 
field of investigation into possible association 
and causuality.2,3 
 Black pigmented, gram negative 
anaerobic pathogens such as Prevotella 
intermedia are involved in both periodontal 
infections and systemic conditions including 
myocardial infarction. A variety of microbes with 
different antimicrobial susceptibility profiles may 
cause periodontal disease, and as such, selection 
of antimicrobial agents should be based on 
proper microbial diagnosis and sensitivity testing 
while taking into consideration the patient’s 
medical status. Patients who fail to stabilize 
following mechanical or surgical therapy are 
often administered antibiotics.4 Thus, the aim of 
the present study was to evaluate the presence 
of Prevotella intermedia as a possible bacterial 
species of significance in patients who present 
with acute myocardial infarction (AMI) and 
chronic periodontitis, and also to examine the 
susceptibility of Prevotella intermedia to nine 
antimicrobial agents. 
Materials and Methods 
A total of 50 subjects were included in the 
present study: 20 were diagnosed with AMI and 
chronic generalized periodontitis (Group I), 20 
were diagnosed with only AMI (Group II), and 
10 healthy controls (Group III).5 Group I and 
Group II patients were admitted to the 
Department of Cardiology, Sri Venkateswara 
Institute of Medical Sciences (SVIMS). Approval 
was obtained from the ethical board of SVIMS 
to conduct the present cross-sectional study. AMI 
was verified by typical changes on an 
electrocardiogram and alteration of serum levels 
of total cholesterol (CHO), high density 
lipoprotein (HDL), low density lipoprotein (LDL), 
triglycerides (TG), creatine kinase (CK), and 
creatine kinase-muscle/brain (CK-MB). All 
subjects had at least 14 teeth and had not 
received periodontal therapy or antibiotics six 
months prior to their recruitment in the present 
study. Group I patients had probing pocket 
depths (PPD) greater than 5 mm and a clinical 
attachment loss (CAL) greater than 1 mm in 
>30% of sites.  Group II and Group III subjects 
had probing pocket depths of less than 3 mm 
and no CAL. 
I. Oral Examination 
AMI patients were clinically examined three to 
four days after admission to the cardiology 
department. A clinical examination was 
administered which assessed the periodontal 
status of each patient and included the following 
parameters: plaque index (PI), gingival index 
(GI), PPD, Russell’s periodontal index, and CAL.6  
II. Laboratory Analysis 
Blood samples were withdrawn from all patients 
upon admission. Serum CHO, HDL, LDL, TG, CK, 
and CK-MB were all determined by means of an 
AutoAnalyzer in the clinical laboratory. 
III. Microbiological Tests 
Culture methods for recovery of bacteria are still 
the gold standard in microbiology. After 
subgingival plaque samples were collected, they 
were immediately transferred to a thyoglycolate 
agar medium (Figure 1). Prevotella intermedia 
was identified in a pure culture grown in a blood 
agar anaerobic medium. Gram staining was 
employed for preliminary identification of 
Prevotella intermedia and its pleomorphic 
morphology. As Prevotella intermedia is an 
aggressive periodontal pathogen, specific 
pathogenic characteristics were identified 
including its proteolytic and fibrinolytic activity 
and the presence of a capsule. Its catalase 
negative characteristic was also identified. 
Figure 1.  Plaque sample collected with paper 
point 
 
IV. Antimicrobial Susceptibility 
An inoculum of 105 CFU was delivered with a 
multipoint inoculator to supplemented Mueller-
Hinton agar. The plates were incubated at 37°C 
for 48 hours in jars filled with a gas mixture 
(85% N2, 5% CO2, 10% H2). The isolated 
Prevotella intermedia strains were tested for 
susceptibility to bacitracin, chloramphenicol, 
penicillin G, polymyxin, gentamycin, neomycin, 
tetracycline, cefotaxime, and cefoxitin using a 
antibiotic zonescalea to determine minimum 
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inhibitory concentrations (MICs). The antibiotic 
zonescale was provided in two hexa disks: Hexa 
Anaerobic-1 and Hexa Universal-1 with 
antibodies; Hexa Anaerobic-1 contained 
tetracycline, cefotaxime, and cefoxitin, while 
Hexa Universal-1 contained bacitracin, 
chloramphenicol, pencillin G, polymyxin, 
gentamycin and neomycin. The lowest 
concentration of antimicrobial agents that 
showed no growth was recorded as the MIC. The 
susceptibility of Prevotella intermedia was 
determined by referring to the MICs zone size 
interpretive standards chart of the National 
Committee for Clinical Laboratory Standards 
(NCCLS), which was provided by HiMedia®.  
Statistical Analysis 
The means and proportions of the major risk 
factors and diagnostic markers for AMI, as well 
as the clinical periodontal parameters were  
calculated for the three groups and the value of 
the F-test and mean within group variances was 
determined by analysis of variance (ANOVA) 
(Tables 1 and 2). The F-test was used to specify 
if a group of variables was jointly significant. 
Results 
Table 1 demonstrates the mean and standard 
deviation (SD) of the clinical periodontal 
parameters for all groups. Mean PI, GI, PPD, 
Russell’s index, and CAL were higher in Group I 
compared to Group II and Group III. The F-value 
was clinically significant. Table 2 demonstrates 
the mean and SD of the major risk factors and 
diagnostic serum enzymes for AMI for all groups. 
Group I showed higher levels of CHO, LDL, TG, 
CK, and CK-MB compared to Group II and 
Group III, whereas HDL were lower in Group I 
compared to Group II and Group III . The F-
value was clinically significant.
Table 1.  Clinical periodontal parameters  
 
High clinical periodontal parameters in Group I compared to Group II and Group III. F-value is 
significant. PI, plaque index; GI, gingival index; PPD, probing pocket depth; and CAL, clinical attachment 
loss. 
 
Table 2.  Lipid profiles and diagnostic serum enzymes for acute myocardial infarction 
 
Low HDL and high LDL, TG, and CHO levels in Group I compared to Group II and Group III. F –value is 
significant. CHO, total cholesterol; HDL, high density lipoprotein; LDL, low density lipoprotein; TG, 
triglycerides; CK, creatine kinase; and CK-MB, creatine kinase-muscle/brain.
 Mean PI Mean GI Mean PPD  
(mm) 
Russell’s 
Periodontal 
Index 
Mean CAL 
(mm) 
Group I 2.73 2.58 6.10 3.22 2.23 
Group II 2.35 1.67 2.20 0.66 0 
Group III 1.16 1.08 1.90 0.70 0 
Significance F = 49.249 F = 58.175 F = 113.436 F = 108.915 F = 52.253 
 Mean CHO 
(mg/dL) 
Mean HDL 
(mg/dL) 
Mean LDL 
(mg/dL) 
Mean TG 
(mg/dL) 
Mean CK 
(U/L) 
Mean CK-MB 
(U/L) 
Group I 260.50 41.45 162.30 341.70 343.85 71.25 
Group II 225.25 42.05 154.90 313.35 223.55 43.80 
Group III 184.00 45.60 121.20 164.00 191.40 37.70 
Significance F = 62.499 F = 2.322 F = 57.832 F = 51.530 F = 6.981 F = 57.832 
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Gram staining and bacterial enzymatic 
reactions demonstrated a higher quantity of 
Prevotella intermedia in Group I compared to 
Group II and Group III. Figure 2 demonstrates 
50% positive bacterial enzymatic reactions in 
Group I, 30% positive enzymatic reactions in 
Group II, and 0% in Group III. Moreover, our 
results revealed that the total bacterial load and 
Prevotella intermedia in specific, was significantly 
higher in Group I compared to Group II and 
Group III in the following order: Group I ˃  
Group II ˃  Group III. 
Table 3 shows the susceptibility of 
Prevotella intermedia to various antibacterials by 
comparing the recorded MICs to the MICs zone 
size interpretive standards chart of the National 
Committee for Clinical Laboratory Standards 
(NCCLS). It was found that pencillin G, 
gentamycin, neomycin, tetracycline, cefotaxime, 
and cefoxitin inhibited 90% of Prevotella 
intermedia whereas bacitracin, chloramphenicol, 
and polymyxin inhibited 80% of Prevotella 
intermedia. Thus, only 10% of Prevotella 
intermedia were resistant to these antibacterial 
drugs.
Figure 2.  Positivity in enzymatic reactions of Prevotella intermedia 
 
 
Table 3.  Antimicrobial susceptibility of Prevotella intermedia   
 
Pencillin G, gentamycin, neomycin, tetracycline, cefotaxime, and cefoxitin inhibited 90% of Prevotella 
intermedia, whereas bacitracin, chloramphenicol, and polymyxin inhibited 80% of Prevotella intermedia. 
 
  
 
Zone Size Interpretative Chart 
Provided by HiMedia® 
MICs Of Prevotella intermedia to Antimicrobial 
Agents in the Present Study (%) 
Antibiotic Resistant 
Intermediate 
Sensitive 
Sensitive Resistant 
Intermediate 
Sensitive 
Sensitive 
Bacitracin 8 mm 9-12 mm 13 mm 20% 30% 50% 
Chloramphenicol 12 mm 13-17 mm 18 mm 20% 20% 60% 
Pencillin  G 13 mm 13-18 mm 18 mm 10% 0% 90% 
Polymyxin 11 mm 10-12 mm 12 mm 20% 10% 70% 
Gentamycin 12 mm 13-14 mm 15 mm 0% 20% 80% 
Neomycin 14 mm 13-16 mm 17 mm 10% 10% 80% 
Tetracycline 14 mm 15-18 mm 19 mm 0% 20% 80% 
Cefotaxime 14 mm 15-22 mm 23 mm 0% 20% 80% 
Cefoxitin 14 mm 15-17 mm 18 mm 0% 10% 90% 
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Discussion 
Periodontal diseases are a group of 
inflammatory conditions of the supporting tissue 
of the teeth caused by bacteria. It is believed 
that bacteria associated with periodontal 
disease enter the bloodstream and travel to 
major organs such as the heart, thereby 
contributing to the formation of artery-clogging 
plaques.5  Black-pigmented, gram-negative oral 
anaerobes such as Prevotella intermedia are 
regarded as pathogens in chronic periodontitis 
and are involved in both oral and non-oral 
infections. 
After assessing the periodontal status 
and lipid profiles in all three groups included in 
the present study, periodontal parameters and 
risk factors were found to be higher in Group I 
compared to Group II and Group III. These 
results are in agreement with Stein et al.10 
 Nonnenmacher et al. and Mane et al. 
found  that Prevotella intermedia was a 
frequently detected  microorganism in 
periodontal disease and was identified by  its 
fibrinolytic and proteolytic activity and by being 
catalase negative and encapsulated.11,12 After 
assessing the periodontal status and lipid 
profiles of all three groups included in the 
present study, we collected  subgingival plaque 
samples in order to test for Prevotella intermedia 
which was identified by phenotypic 
characteristics demonstrated through bacterial 
Gram staining and culture methods. These 
methods confirmed the presence of Prevotella 
intermedia in subgingival plaque samples of both 
chronic periodontitis and AMI patients. 
       Patients who do not respond to common 
mechanical or surgical periodontal therapy are 
often administered antibiotics as an adjunct to 
conventional treatment. According to Andrés et 
al. 14% of Prevotella intermedia were resistant 
to β-lactam antibiotics (pencillins and/or 
cephalosporins) whereas our study shows that 
only 10% were resistant to these antibiotics.4   
It may be warranted to stabilize the 
periodontal condition of patients with 
cardiovascular disease through non-surgical 
therapy that includes both scaling and root 
planing (SRP) and adjunctive antimicrobial 
therapy. The fact that the load of Prevotella 
intermedia was higher in the chronic periodontitis 
and AMI group (Group I) compared to the other 
groups, and that the load was higher in the AMI 
group (Group II) compared to the healthy control 
group (Group III), hints to the possibility that this 
particular pathogen may be linked to the onset 
of cardiovascular disease. 
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